Developing antibody-based drugs against targets identified using its primary B-cell selection and evolution platform.
Amsterdam, The Netherlands
Joined March 2024
- Tweets42
- Following129
- Followers10
- Likes5
Developing antibody-based drugs against targets identified using its primary B-cell selection and evolution platform.